arrow
Back
T

Tony Mok

the chinese university of hong kong

131H-index
1.1KPaper Count
10.6WCitation Count
Published Papers 265
Publication Date
Retraction Note: Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial
err2026-06-24
err0
PREAI
errZhe Huang; Liang Zeng; Zhaohui Ruan; Qun Zeng; Huan Yan; Wenjuan Jiang; Yi Xiong; Chunhua Zhou; Haiyan Yang; Li Liu; Jiacheng Dai; Nachuan Zou; Shidong Xu; Ya Wang; Zhan Wang; Jun Deng; Xue Chen; Jing Wang; Hua Xiang; Xiaomei Li; Boris Duchemann; Guoqiang Chen; Yang Xia; Tony Mok; Christoph Scheiermann; Francis Lévi; Nong Yang; Yongchang Zhang
errShare
errSave
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
err2026-02-02
err0
PREAI
errZhe Huang; Liang Zeng; Zhaohui Ruan; Qun Zeng; Huan Yan; Wenjuan Jiang; Yi Xiong; Chunhua Zhou; Haiyan Yang; Li Liu; Jiacheng Dai; Nachuan Zou; Shidong Xu; Ya Wang; Zhan Wang; Jun Deng; Xue Chen; Jing Wang; Hua Xiang; Xiaomei Li; Boris Duchemann; Guoqiang Chen; Yang Xia; Tony Mok; Christoph Scheiermann; Francis Lévi; Nong Yang; Yongchang Zhang
errShare
errSave
Precise diagnosis of small invasive pulmonary nodules driven by single-cell immune signatures in peripheral blood
err2025-12-08
err0
errOAAI
errYang Xia; Yin Zhu; Sai Zhang; Mo Zhou; Jiaqi Zhou; Guanxin Xu; Baiqin Zhao; Guofei Zhang; Qiyuan Wang; Bin Wang; Zexin Chen; Hongyu Shi; Xiuning Le; Tony Mok; Wei Chen; Junqiang Fan; Weiwei Yin; Wen Li
errShare
errSave
Robotic-assisted and electromagnetic navigation bronchoscopy for multi-focal lung cancers: a narrative review
err2025-11-30
err0
PREAI
errLiu, Wei; Chang, Aliss T. C.; Chan, Joyce W. Y.; Lau, Rainbow W. H.; Mok, Tony S. K.; Ng, Calvin S. H.
errShare
errSave
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
err2025-11-11
err0
PREAI
errJing Zhao; Wanting Xu; Fei Zhou; Xiangyu Zhang; Mo Zhou; Da Miao; Lan Yu; Yongchang Zhang; Junqiang Fan; Caicun Zhou; Wen Li; Tony Mok; Xiuning Le; Molly Li; Yang Xia
errShare
errSave
Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib
err2025-11-01
err0
PREAI
errAllen C.C. Chen; Florence S.T. Mok; Wesley Wong; Benjamin H.W. Lam; David Johnson; Matthew M.P. Lee; Landon L. Chan; Frankie Mo; Kevin K.S. Mok; Olivia H. Chen; Kirsty Lee; Herbert H.F. Loong; K.C. Lam; Kelvin Yan; Tony S.K. Mok; Molly S.C. Li
errShare
errSave
A comparison of clinical guidelines; treatment characteristics and outcomes in small cell lung cancer between East Asia and Europe/North America
err2025-10-27
err0
errOAAI
errChi-Lu Chiang; Ross Andrew Soo; Tony Mok; Pei Jye Voon; Lucksamon Thamlikitkul; Ying Cheng; Hidehito Horinouchi; Byong Chul Cho; Krista Lin Xu; Myung-Ju Ahn†
errShare
errSave
Efficacy and safety of brigatinib after alectinib in patients with ALK-positive NSCLC: Integrated analysis of the ALTA-2 and J-ALTA studies
err2025-10-09
err0
PREAI
errTony Mok; Makoto Nishio; Tatsuya Yoshida; Myung-Ju Ahn; Kentarou Kudou; Takayuki Asato; Hui Yang; Xin Tong; Sylvie Vincent; Pingkuan Zhang; Nobuyuki Yamamoto; Edward S. Kim
errShare
errSave
Establishing the China–UK Cancer Prevention and Control Alliance
err2025-09-01
err0
PREAI
errJun Ma; David Kerr; Yuankai Shi; Charles Swanton; Tony Mok; Rebecca Fitzgerald; Rui-Hua Xu; Richard Cowan; Rong Lin; Mark Lawler; Gao-Jun Teng; Tim Eisen; Molly Li; Maria Kyrgiou; Fanny Wai San Ko; Mark Middleton; Binghe Xu; Eric Aboyage; Dan Xiao; Yi-Long Wu; Arnie Puroshotham; Li Yang; Daiming Fan
errShare
errSave
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
err2025-08-07
err0
PREAI
errFabrice Barlesi; Wenxiu Yao; Michaël Duruisseaux; Ludovic Doucet; Aitor Azkárate Martínez; Vanesa Gregorc; Oscar Juan-Vidal; Shun Lu; Charlotte De Bondt; Filippo de Marinis; Helena Linardou; Young-Chul Kim; Robert Jotte; Enriqueta Felip; Giuseppe Lo Russo; Martin Reck; Mary F Michenzie; Wenjing Yang; Julie N Meade; Beata Korytowsky; Tony S K Mok
errShare
errSave
Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts
err2025-07-10
err0
errOAAI
errNancee Pronsati; Geoffrey Liu; Todd M. Bauer; Enriqueta Felip; Yasushi Goto; Gerald Green; Mary Grizzard; Michael Hamel; Julien Mazieres; Tony Mok; Stephanie Snow; Benjamin J. Solomon; Jan Stratmann; Ken Culver
errShare
errSave
Durvalumab with or without tremelimumab in combination with chemotherapy in first-line metastatic non-small-cell lung cancer: outcomes by tumor mutational burden in POSEIDON
err2025-05-01
err0
errOAAI
errPeters, S.; Oliner, K. S.; Hernault, A. l '; Ratcliffe, M.; Madison, H.; Lai, Z.; Stewart, R.; Mann, H.; Lowery, C.; Garon, E. B.; Mok, T.; Johnson, M. L.
errShare
errSave
Debate on first-line treatment strategies in advanced non-small cell lung cancer with EGFR mutation: An expert panel meeting by the Italian Association of Thoracic Oncology (AIOT)
err2025-03-01
err0
PREAI
errGridelli, Cesare; Mok, Tony; Janne, Pasi; Passaro, Antonio; Felip, Enriqueta; Ramalingam, Suresh S.; Attili, Ilaria
errShare
errSave
Germline Human Leukocyte Antigen Status is Associated With Immunotherapy-Induced Pneumonitis and Treatment Response in Patients With Non-Small Cell Lung Cancer With High Programmed Death-Ligand 1 Expression
err2025-01-01
err0
errOAAI
errCheung, Alvin H. K.; Mui, Zeta; Yeung, Walter W.; Chow, Chit; Yu, Mandy F.; Chen, Olivia H.; Wong, Kit-Yee; Xie, Fuda; Lau, Yat Ming; Cheng, Alfred S. -L.; Kang, Wei; To, Ka-Fai; Mok, Tony S.; Li, Molly S. C.
errShare
errSave
Next-generation immunotherapy: igniting new hope for lung cancer
err2024-12-07
err0
errOAAI
errLi, Molly S. C.; Chan, Andrew L. S.; Mok, Kevin K. S.; Chan, Landon L.; Mok, Tony S. K.
errShare
errSave
Lung cancer research and treatment: global perspectives and strategic calls to action
err2024-12-01
err0
PREAI
errMeyer, M. -l.; Peters, S.; Mok, T. S.; Lam, S.; Yang, P. -c.; Aggarwal, C.; Brahmer, J.; Dziadziuszko, R.; Felip, E.; Ferris, A.; Forde, P. M.; Gray, J.; Gros, L.; Halmos, B.; Herbst, R.; Jaenne, P. A.; Johnson, B. E.; Kelly, K.; Leighl, N. B.; Liu, S.; Lowy, I.; Marron, T. U.; Paz-Ares, L.; Rizvi, N.; Rudin, C. M.; Shum, E.; Stahel, R.; Trunova, N.; Bunn, P. A.; Hirsch, F. R.
errShare
errSave
Consensus on the lung cancer management after third-generation EGFR-TKI resistance
err2024-12-01
err0
errOAAI
errZhou, Qing; Zhao, Hongyun; Lu, Shun; Cheng, Ying; Liu, Ying; Zhao, Mingfang; Yu, Zhuang; Hu, Chengping; Zhang, Li; Yang, Fan; Zhao, Jun; Guo, Renhua; Ma, Rui; Du, Yingying; Dong, Xiaorong; Cui, Jiuwei; Tan, Daniel S. W.; Ahn, Myung-Ju; Tsuboi, Masahiro; Liu, Si-Yang Maggie; Mok, Tony S.; Wu, Yi-Long
errShare
errSave
Patterns of disease progression and efficacy of local ablative therapy among patients with metastatic EGFR-mutation positive non-small cell lung cancer treated with fi rst-line osimertinib
err2024-12-01
err0
PREAI
errChen, C. C. A.; Chen, O. H.; Mok, K.; Lam, K. C.; Lee, W. C. K.; Mok, S. T. F.; Ng, T. Y. J.; Johnson, D.; Chan, L. L.; Yan, K. C. K.; Wong, W.; Lam, B.; Lee, M. P.; Mok, T. S. K.; Li, S. C. M.
errShare
errSave
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer
err2024-10-03
err0
errOAAI
errSolomon, Benjamin J.; Liu, Geoffrey; Felip, Enriqueta; Mok, Tony S. K.; Soo, Ross A.; Mazieres, Julien; Shaw, Alice T.; de Marinis, Filippo; Goto, Yasushi; Wu, Yi-Long; Kim, Dong-Wan; Martini, Jean-Francois; Messina, Rossella; Paolini, Jolanda; Polli, Anna; Thomaidou, Despina; Toffalorio, Francesca; Bauer, Todd M.
errShare
errSave
Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050
err2024-10-03
err1
errOAAI
errPu, Xingxiang; Li, Juan; Zhang, Bo; Zhang, Jinyao; Mok, Tony S.; Nakagawa, Kazuhiko; Rosell, Rafael; Cheng, Ying; Zhou, Xiangdong; Miglorino, Maria Rita; Niho, Seiji; Lee, Ki Hyeong; Corral, Jesus; Pluzanski, Adam; Li, Junling; Linke, Rolf; Pan, Fang; Tang, Yiyun; Tan, Weiwei; Wu, Lin
errShare
errSave